Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...
The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, ...
Avery - whose real name is Anna Iannitelli - recently shared a video to Instagram, where she claimed she had been diagnosed ...
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.
A singer has said that she was diagnosed with osteoporosis after she used Ozempic, a drug not licensed for weight loss ...
TUESDAY, Jan. 14, 2025 (HealthDay News) -- Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, ...
“While Novo Nordisk recognises that some healthcare providers may be prescribing Ozempic (semaglutide injection) for patients whose goal is to lose weight, we do not promote, suggest, or ...